Mandibular Repositioning Appliances: Evidence-Based OSA Guide

Obstructive Sleep Apnea (OSA) has transitioned from a niche sleep lab concern to a global public health priority. Recent epidemiological data reveals a staggering prevalence: approximately 84% of men and 61% of women aged 40 and older present with an Apnea-Hypopnea Index (AHI) of ≥ 5. Postmenopausal women often reach parity with men in terms of prevalence, and the incidence continues to climb until the seventh and eighth decades of life. Beyond the statistics, the stakes are high: untreated OSAS is a potent driver of cerebrovascular accidents, myocardial infarction, congestive heart failure, and metabolic syndrome. While many of these cases represent milder forms of the disease, particularly in younger demographics, the sheer volume of potential patients has ignited a critical discussion regarding treatment necessity and the limitations of traditional "one-size-fits-all" interventions.

Defining Severity: The AHI Benchmark

To treat OSAS effectively, the dental clinician must speak the language of the sleep physician. The diagnosis is confirmed via Polysomnography (PSG), which yields the Apnea-Hypopnea Index (AHI) – the number of respiratory events per hour.

The Shift Toward Mandibular Repositioning Appliances (MRA)

While Continuous Positive Airway Pressure (CPAP) remains the gold standard for severe cases, patient adherence continues to be a clinical hurdle. Consequently, Mandibular Repositioning Appliances (MRAs), a specialized subset of Oral Appliances (OAs), have emerged as a highly effective, patient-preferred alternative.

For the modern dental clinician, staying updated on the evolving evidence surrounding MRA therapy is no longer optional. This review synthesizes current clinical data to explore the "why" and "how" of MRA therapy, covering everything from precise indications and device design to long-term health outcomes and side-effect management.

The Mechanism of Action

The primary therapeutic goal of an MRA is to physically alter the upper airway geometry. By repositioning the mandible anteriorly, the appliance achieves several key physiological objectives:

• Airway Expansion: Increases the total volume of the upper airway, specifically targetting the lateral dimension at the velopharyngeal level.

• Neuromuscular Tensioning: By promoting anterior traction of the mandible, the MRA increases tension in the genioglossus muscle and the supra- and infrahyoid muscles. This mechanical pull expands the pharyngeal airspace and prevents the collapse of oropharyngeal tissues and the base of the tongue.

• Pathophysiological Impact: While MRAs primarily address anatomical abnormalities and pharyngeal collapsibility, they differ from CPAP in that they typically do not alter loop gain or arousal thresholds.
• Systemic Benefit: Beyond "stopping the snoring," MRAs are proven to reduce blood pressure and endothelial function has been shown in some studies to improve, making them a true medical intervention in a dental format.

Recent Cone Beam Computed Tomography (CBCT) studies have redefined our understanding of MRA action:

• Vertical Increase: Mandibular protrusion creates a linear vertical increase between the maxilla and mandible.
• Hyoid Rotation: The hyoid bone undergoes anterosuperior displacement and rotation, which is a critical marker for successful airway expansion.
• Lateral Expansion: The greatest changes are often seen in the transversal dimension, particularly at the retropalatal and retro-lingual spaces.

Professional Development Opportunity: To master the complex relationship between masticatory muscle activity and airway patency, we invite you to enroll in the "Bruxism And Apnea Treatment" online course. This program features 9 intensive lessons from a global faculty of experts, providing evidence-based protocols for diagnosing and treating the intersection of these dual pathologies across all age groups.

Patient Selection & Predictors of Success

Evidence suggests that patients with mild to moderate OSA are the ideal candidates for MRA therapy. These individuals generally possess less collapsible airways and exhibit more significant pharyngeal expansion along the entire length of the airway compared to severe OSA patients.

However, the utility of the MRA is not limited to mild cases. In clinical practice, the MRA serves as:

1. A Primary Therapy for mild-to-moderate OSA.
2. A Secondary Line of Defense for CPAP-intolerant patients, regardless of severity.
3. Combination Therapy, used alongside positional therapy or even CPAP to reduce the pressure requirements of the machine, thereby improving overall comfort and compliance.

This phenotypes may help estimate likelihood of response, though prediction remains imperfect:

• Strong Predictors: Younger age, female gender, lower BMI, lower neck circumference.
• Anatomical Predictors: Mandibular/maxillary retrognathism and positional OSA (supine-dependent).
• Physiological Markers: Lower CPAP therapeutic pressure requirements and primary oropharyngeal collapse.

One of the most significant challenges in MRA therapy is the variability in treatment response. Unlike the predictable pneumatic splint of CPAP, MRA success depends on a complex interplay of factors:

• Anatomy & Position: A greater degree of mandibular advancement generally yields better AHI reduction, though the relationship is not always linear. The success of the MRA may be less dependent on single-level obstruction (whether primary obstruction is in the oropharynx, the hypopharynx, or both) than previously thought.
• Predictive Phenotyping: Emerging research highlights that patients with lower "loop gain" (a less sensitive ventilatory control system) and a less collapsible passive airway anatomy respond most favorably.
• Clinical Indicators: Success can often be predicted by observing pharyngeal widening via nasendoscopy or utilizing remotely controlled mandibular positioners (RCMP) during an overnight titration test.

Device Taxonomy: Selecting the Right Tool

Not all appliances are created equal. The distinction between "prefabricated" and "custom-made" is the difference between a gadget and a medical device.

Coupling Mechanisms & Design Philosophy

• Monoblock vs. Bi-block: Bi-block (two-piece) adjustable designs are the modern standard, allowing for lateral movement and progressive titration.
• Lateral Coupling: Mechanisms with lateral fins or bars offer greater tongue space and lateral freedom, significantly improving comfort.
• The Vertical Dimension: Modern evidence suggests avoiding excessive vertical increase. Too much inter-incisal distance can cause posterior rotation of the mandible, leading to a more retrusive position and reduced efficacy.
• The Need for Customization: "Boil-and-bite" or non-titratable devices lack the retention and precision required for therapeutic success.

Clinical Contraindications: Identifying the "No-Go" Patient

Before initiating MRA therapy, a thorough intraoral and functional assessment is mandatory. Success depends on the appliance having a stable, pain-free foundation.

Dental & Periodontal Requirements

An MRA exerts significant forces on the dentition to maintain the mandible in a protruded position.

• Minimum Tooth Count: Patients generally require at least 10 healthy, stable teeth per arch. This ensures adequate retention and distributes the mechanical load.
• Periodontal Stability: Active, untreated periodontal disease or Grade II/III tooth mobility are absolute contraindications. The forces of the appliance can accelerate bone loss or lead to tooth migration/loss.
• Active Decay: All caries and failing restorations must be addressed prior to the final impression. Post-fitting dental work (crowns, bridges) will often render a custom MRA non-functional due to fit changes.

Functional & TMJ Limitations

• Restricted Protrusion: Patients must have a minimum protrusive capacity (typically $\ge 5$ mm). If the patient cannot move their jaw forward comfortably, the device cannot reach a therapeutic position.
• Severe TMD: While mild TMJ discomfort is not always a contraindication, patients in an active inflammatory phase of Temporomandibular Disorder (TMD) or those with severe disc displacement with reduction should be managed for TMD before MRA therapy.
• Gag Reflex: A hyperactive gag reflex can significantly hinder compliance, though custom-made, low-profile designs (like the Narval or digital milled devices) often mitigate this.

Medical Considerations

• Central Sleep Apnea (CSA): MRAs are designed to address mechanical obstruction. They are ineffective for CSA, where the issue is a lack of respiratory drive from the brain.
• Cognitive or Physical Impairment: The patient must have the manual dexterity to insert, remove, and clean the device. Similarly, they must be able to recognize and report discomfort.

The Titration Journey

The goal of MRA therapy is to find the "Sweet Spot" where the AHI is minimized without inducing temporomandibular joint (TMJ) distress. Success with an MRA isn't achieved on the day of delivery. It is a physiological adaptation process:

1. Adaptation Phase (approx. 4 weeks) and Initial Position: The patient acclimates to the presence of the device and the initial vertical/anterior shift. Start at approximately 50% of the patient’s maximum protrusive range.
2. Titration Phase (2–3 months): Stepwise advancement of the mandible. Advancement should occur in increments of ≤ 1.0 mm.
3. Total Range: A minimum adjustment range of 5 mm is necessary for clinical flexibility.
4. The "Sweet Spot": Clinical evidence suggests that a protrusion of 50% to 75% of the patient's maximum voluntary protrusion typically yields the most favorable respiratory outcomes without inducing TMJ distress.

Clinical Pearl: Because MRA success is less predictable than the "pneumatic splint" of a CPAP, objective follow-up is mandatory. Every patient fitted with an MRA should ideally undergo a follow-up sleep study to confirm the device provides satisfactory control of the AHI.

The "Gateway" to Success: The Pre-MRA Checklist

For the clinical team, the workflow should follow this evidence-based path:

1. Sleep Study (PSG/HSAT): Confirm diagnosis and baseline AHI.
2. Comprehensive Dental Exam: Assess periodontal health and the "10-tooth rule".
3. TMD Screening: Evaluate range of motion and joint stability.
4. Device Selection: Choose a custom-made, titratable Bi-block design.
5. Titration & Adaptation: Gradual advancement over 2-3 months.
6. Validation: Follow-up sleep study to confirm efficacy.

Long-Term Management: The "Side Effect" Reality

As a qualified MAD provider, transparency with the patient regarding occlusal changes is vital. While short-term effects (salivation, transient muscle pain) are manageable, long-term use (6+ months) often leads to progressive dental shifts:

1. Decreased Overbite/Overjet: The most common finding.
2. Incisor Inclination: Lingual tilt of upper incisors and vestibular (labial) tilt of lower incisors.
3. Posterior Open Bite: Resulting from the mesialization of the lower molars.

The "Average Disease Relief" Concept: Even though CPAP is technically more efficient at reducing AHI, the MRA may achieve comparable real-world cardiovascular risk reduction in some populations. Why? Because patients actually wear them. This "Mean Disease Outcome" makes the MRA a powerhouse in real-world clinical practice.

Conclusion: The Dentist as a Sleep Specialist

The transition from a "dentist who makes mouthguards" to a qualified MAD provider requires expertise in:

• Screening: Identifying OSA signs in the dental chair.
• Selection: Choosing the right coupling mechanism for the patient's anatomy.
• Monitoring: Objective follow-up with sleep tests (not just subjective feedback).

In the modern medical landscape, the dentist is no longer just "fixing teeth", they are a vital partner in managing a life-threatening systemic disease.

To bridge the gap between general dental practice and advanced sleep science, we invite you to  access the comprehensive online course "Apnea: Diagnostics And Treatment. Dental Sleep Medicine", which features 12 in-depth lessons led by a global faculty of experts. This program provides 10 hours of intensive training covering everything from diagnostics and appliance selection to advanced neuromuscular treatment protocols, ensuring you meet the highest standards of care for the modern sleep medicine team.